Seminars in Nuclear Medicine
Volume 32, Issue 3 , Pages 193-211 , July 2002

Gallium and other agents in diseases of the lung

  • David M. Schuster

      Affiliations

    • Emory University Hospital, Atlanta, GA, USA
    • Atlanta Veterans Affairs Medical Center, Atlanta, GA, USA
    • Corresponding Author InformationAddress reprint requests to David M. Schuster, MD, Dept. of Nuclear Medicine (E145), Emory University Hospital, 1364 Clifton Rd, NE, Atlanta, GA 30322
    • ,
  • Naomi Alazraki

      Affiliations

    • Emory University Hospital, Atlanta, GA, USA
    • Atlanta Veterans Affairs Medical Center, Atlanta, GA, USA

References 

  1. Edward CL, Hayes RL. Tumor scanning with Ga-67 citrate. J Nucl Med. 1969;10:103–105
  2. Lavendar JP, Lowe J, Baker JR, et al. Gallium-67 citrate scanning in neoplastic and inflammatory lesions. Br J Radiol. 1971;44:361–366
  3. Littenberg RL, Taketa RM, Alazraki NP, et al. Gallium-67 for localization of septic lesions. Ann Intern Med. 1973;79:403–406
  4. Nejmeddine F, Raphael M, Martin A, et al. Ga-67 scintigraphy in B-cell non-Hodgkin's lymphoma: Correlation of Ga-67 uptake with histology and transferrin receptor expression. J Nucl Med. 1999;40:40–45
  5. Van der Wall H, McLaughlin AF, Southee AE. Gallium scintigraphy in tumor diagnosis and management. In: Murray IPC, Ell PJ editor. Nuclear Medicine in Clinical Diagnosis and Treatment. ed 2. New York, NY: Churchill Livingstone; 1998;p. 813–815
  6. Hoffer PB, Miller-Catchpole R, Turner DA. Demonstration of lactoferrin in tumor tissue from two patients with positive gallium scans. J Nucl Med. 1979;20:424–427
  7. Hoffer PB, Huberty J, Khazan-Bushi H. The association of 67Ga and lactoferrin. J Nucl Med. 1977;18:713–717
  8. Tsan MF, Chen WY, Scheffel U, et al. Mechanism of gallium localization in inflammatory lesions. J Nucl Med. 1977;18:619
  9. Bitar RA, Scheffel U, Murphy PA, et al. Accumulation of indium-111 labeled neutrophils and gallium-67 citrate in rabbit abscesses. J Nucl Med. 1986;12:1883–1889
  10. Sfakianakis GN, Al-Sheikh W, Heal , et al. Comparisons of scintigraphy with In-111 leukocytes and Ga-67 in the diagnosis of occult sepsis. J Nucl Med. 1982;7:618–626
  11. Higashi T, Kobayashi M, Wakao H, et al. The relationship between 67Ga accumulation and ATP metabolism in tumor cells in vitro. Eur J Nucl Med. 1989;15:152–156
  12. Taylor A, Schuster D, Alazraki N. A Clinician's Guide to Nuclear Medicine. In: Reston, VA: Society of Nuclear Medicine; 2000;p. 139–143
  13. Abdel-Dayem HM, Scott A, Maeaplinae H, et al. Thallium-201 chloride: A tumor imaging agent. In: Murray IPC, Ell PJ editor. Nuclear Medicine in Clinical Diagnosis and Treatment. ed 2. New York, NY: Churchill Livingstone; 1998;p. 831–841
  14. Waxman AD, Eller D, Ashook G, et al. Comparison of gallium-67 citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma. J Nucl Med. 1996;37:46–50
  15. Ramanna L, Waxman AD, Waxman S, et al. Tl-201 scintigraphy in bone and soft tissue sarcoma: Evaluation of tumor mass and viability. J Nucl Med. 1988;22:553–555
  16. Rosen G, Loren GJ, Brien EW, et al. Serial Tl-201 scintigraphy in osteosarcoma: Correlation with tumor necrosis after preoperative chemotherapy. Clin Orthop. 1993;293:302–306
  17. Matsuno S, Tanabe M, Kawasaki Y, et al. Effectiveness of planar image and single photon emission tomography of thallium-201 compared with gallium-67 in patients with primary lung cancer. Eur J Nucl Med. 1992;19:86–95
  18. Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: Clinical and pathological follow-up. J Nucl Med. 1995;36:1784–1789
  19. Villanueva-Meyer J, Briscoe LJE, Cesani F, et al. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med. 1996;37:926–930
  20. Taylor A, Schuster D, Alazraki N. A Clinician's Guide to Nuclear Medicine. In: Reston, VA: Society of Nuclear Medicine; 2000;p. 259
  21. Blum J, Handmaker H, Lister-James J, et al. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules. Chest. 2000;117:1232–1238
  22. Rehm P. Radionuclide evaluation of patients with lymphoma. Radiol Clin North Am. 2001;39:957–978
  23. Van der Wall H, McLaughlin A, Southee A. Gallium scintigraphy in tumor diagnosis and management. In: Murray IPC, Ell PJ editor. Nuclear Medicine in Clinical Diagnosis and Treatment. ed 2. New York, NY: Churchill Livingstone; 1998;p. 817–823
  24. Rudders R, McCaffrey JA, Kahn P. The relative roles of gallium-67 citrate scanning and lymphangiography in the current management of malignant lymphoma. Cancer. 1977;40:1439–1443
  25. Jochelson MS, Herman TS, Stomper PC, et al. Planning mantle radiation therapy in patients with Hodgkin's disease: Role of gallium-67 scintigraphy. AJR Am J Roentgenol. 1988;151:1229–1231
  26. Tumeh SS, Rosenthal DS, Kaplan WD, et al. Lymphoma: Evaluation with Ga-67 SPECT. Radiology. 1987;16:111–114
  27. Zinzani PL, Magagnoli M, Franchi R, et al. Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement. Haematologica. 1999;84:604–607
  28. Zinzani PL, Martelli M, Magagnoli M, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67) gallium scan in 50 patients. Blood. 1999;94:3289–3293
  29. Ionescu I, Brice P, Simon D, et al. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients. Med Oncol. 2000;17:127–134
  30. Ulusakarya A, Lumbroso J, Casiraghi O, et al. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma. Leuk Lymphoma. 1999;35:579–586
  31. Weiner M, Leventhal B, Cantor A, et al. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study. Cancer. 1991;68:2478–2480
  32. Rossleigh MA, Murray IP, Mackey DW, et al. Pediatric solid tumors: Evaluation by gallium-67 SPECT studies. J Nucl Med. 1990;31:168–172
  33. Van der Wall HVD, Murray IPC, Huckstep RL, et al. The role of thallium scintigraphy in excluding malignancy in bone. Nucl Med Commun. 1993;18:551–557
  34. Lee VW, Fuller JD, O'Brien MJ, et al. Pulmonary Kaposi sarcoma in patients with AIDS: Scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology. 1991;180:409–412
  35. Alazraki N, Ramsdell J, Taylor A, et al. Reliability of gallium scan chest radiography compared to mediastinoscopy for evaluating mediastinal spread in lung cancer. Am Rev Respir Dis. 1978;117:415–420
  36. De Meester TR, Bekerman C, Joseph JG, et al. Gallium-67 scanning for carcinoma of the lung. J Thorac Cardiovasc Surg. 1976;72:699–708
  37. MacMahon H, Scott W, Ryan JW, et al. Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer. Cancer. 1989;64:1404–1408
  38. Buccheri G, Vola F, Ferrigno D, et al. Lack of clinical significance of gallium-67 uptake in non-small cell lung cancer. Eur J Respir Dis. 1987;71:356–361
  39. Yamamoto Y, Nishiyama Y, Kawasaki Y, et al. Evaluation of 99mTc-MIBI to predict chemotherapeutic response in patients with small cell lung carcinoma. Nippon Igaku Hoshasen Gakkai Zasshi. 1996;56:980–981
  40. Shiojima K, Tamaki Y, Hashida I, et al. Gallium-67 scintigraphy in evaluation of malignant lymphoma of the thyroid gland. Radiat Med. 1996;14:31–34
  41. Yoshida S, Fukumoto M, Motohara T, et al. Ga-67 tumor scan in malinant diffuse mesothelioma—Comparison with CT and pathological findings. Ann Nucl Med. 1999;1:49–54
  42. Fink G, Krelbaum T, Yellin A, et al. Pulmonary carcinoid: Presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest. 2001;6:1647–1651
  43. Siemsen JK, Grebe SF, Sargent EN, et al. Gallium-67 scintigraphy of pulmonary diseases as a complement to radiography. Radiology. 1976;118:371–375
  44. Puryear DW, Fowler AA. Sarcoidosis: A clinical overview. Compr Ther. 1996;22:649–653
  45. Lynch JP, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med. 1997;18:755–785
  46. Sulavik SB, Spencer RP, Weed DA, et al. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med. 1990;31:1909–1914
  47. Sulavik SB, Spencer RP, Palestro CJ, et al. Specificity and sensitivity of distinctive chest radiographic and/or Ga-67 images in the noninvasive diagnosis of sarcoidosis. Chest. 1993;103:403–409
  48. Mana J. Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med. 1997;18:799–811
  49. Kramer EL, Divgi CR. Pulmonary applications of nuclear medicine. Clin Chest Med. 1991;12:55–75
  50. Thrall JH, Ziessman HA. Infection and inflammation, in Nuclear Medicine: The Requisites. In: St Louis, MO: Mosby-Year Book; 1995;p. 154
  51. Bisson G, Drapeau G, Lamoureux G, et al. Computerbased quantitative analysis of gallium-67 uptake in normal and diseased lungs. Chest. 1983;84:513–517
  52. Fajman WA, Greenwald LV, Staton G, et al. Assessing the activity of sarcoidosis: Quantitative 67Ga-citrate imaging. AJR Am J Roentgenol. 1984;142:683–688
  53. Braude AC, Cohen R, Rahmani R, et al. An in-vitro gallium-67 lung index for the evaluation of sarcoidosis. Am Rev Respir Dis. 1984;130:783–785
  54. Johnson DG, Johnson SM, Harris CC, et al. Ga-67 uptake in the lung in sarcoidosis. Radiology. 1984;150:551–555
  55. Rizzato G, Blasi A. A European survey on the usefulness of 67Ga lung scans in assessing sarcoidosis. Experience in 14 research centers in seven different countries. Ann N Y Acad Sci. 1986;465:463–478
  56. Rohatgi PK, Singh R, Vieras F. Extrapulmonary localization of gallium in sarcoidosis. Clin Nucl Med. 1987;12:9–16
  57. Sulavik SB, Palestro CJ, Spencer RP, et al. Extrapulmonary sites of radiogallium accumulation in sarcoidosis. Clin Nucl Med. 1990;15:876–878
  58. Nosal A, Schleissner LA, Mishkin FS, et al. Angiotensin converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis. Ann Intern Med. 1979;90:328–331
  59. Hollinger WM, Staton GW, Fajman WA, et al. Prediction of therapeutic response in steroid-treated pulmonary sarcoidosis. Evaluation of clinical parameters, bronchoalveolar lavage, gallium-67 lung scanning, and serum angiotensin-converting enzyme levels. Am Rev Respir Dis. 1985;132:65–69
  60. Baughman RP, Fernandez M, Bosken CH, et al. Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Predicting response to therapy. Am Rev Respir Dis. 1984;129:676–681
  61. Turner-Warwick M, McAllister W, Lawrence R, et al. Corticosteroid treatment in pulmonary sarcoidosis: Do serial lavage, lymphocyte counts, serum angiotensin-converting enzyme measurements, and gallium-67 scans help management?. Thorax. 1986;41:903–913
  62. Baughman RP, Shipley R, Eisentrout CE. Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in 2-year follow-up of pulmonary sarcoidosis. Lung. 1987;165:371–377
  63. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 1994;35:1647–1649
  64. Alavi A, Buchpiguel CA, Loessner A. Is there a role for FDG PET imaging in the management of patients with sarcoidosis?. J Nucl Med. 1994;35:1650–1652
  65. Aktolun C, Bayhan H. Tc-99m MIBI uptake in pulmonary sarcoidosis. Preliminary clinical results and comparison with Ga-67. Clin Nucl Med. 1994;19:1063–1065
  66. Bradvik I, Wollmer P, Evander E, et al. Different kinetics of lung clearance of technetium-99m labelled diethylene triamine penta-acetic acid in patients with sarcoidosis and smokers. Eur J Nucl Med. 1994;21:1218–1222
  67. Ozturk E, Gunalp B, Ozguven M, et al. The visualization of granulomatous disease with somatostatin receptor scintigraphy. Clin Nucl Med. 1994;19:129–132
  68. Moinuddin M, Rockett J. Gallium scintigraphy in the detection of amiodarone lung toxicity. AJR Am J Roentgenol. 1986;147:607–609
  69. van Rooij WJ, van der Meer SC, van Royen EA, et al. Pulmonary gallium-67 uptake in amiodarone pneumonitis. J Nucl Med. 1984;25:211–213
  70. Lecklitner ML, Johnson DR, Hughes JJ. Gallium-67 and pulmonary complications of amiodarone. Clin Nucl Med. 1988;13:826–828
  71. Richman SD, Levenson SM, Bunn PA, et al. 67Ga accumulation in pulmonary lesions associated with bleomycin toxicity. Cancer. 1975;36:1966–1972
  72. Garbes ID, Henderson ES, Gomez GA, et al. Procarbazine-induced interstitial pneumonitis with a normal chest x-ray: A case report. Med Pediatr Oncol. 1986;14:238–241
  73. MacMahon H, Bekerman C. The diagnostic significance of gallium uptake in patients with normal chest radiographs. Radiology. 1978;127:189–193
  74. Crook MJ, Kaplan PD, Adatepe MH. Gallium-67 scanning in nitrofurantoin-induced pulmonary reaction. J Nucl Med. 1982;23:690–692
  75. Stein MG, DeMarco T, Gamsu G, et al. Computed tomography: Pathologic correlation in lung disease due to tocainide. Am Rev Respir Dis. 1988;137:458–460
  76. Manning DM, Strimlan CV, Turbiner EH. Early detection of busulfan lung: Report of a case. Clin Nucl Med. 1980;5:412–414
  77. Lentle BC, Castor WR, Khaliq A, et al. The effect of contrast lymphangiography on localization of 67Ga-citrate. J Nucl Med. 1975;16:374–376
  78. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation. 1990;82:51–59
  79. Zhu YY, Botvinick E, Dae M, et al. Gallium lung scintigraphy in amiodarone pulmonary toxicity. Chest. 1988;93:1126–1131
  80. Xaubet A, Roca J, Rodriguez-Roisin R, et al. Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis. Respiration. 1987;52:272–280
  81. Bekerman C, Hoffer PB, Bitran JD, et al. Gallium-67 citrate imaging studies of the lung. Semin Nucl Med. 1980;10:286–301
  82. Freeman CR, Lisbona R, Palayew M. Lung scanning with 67gallium citrate for detection of acute radiation changes. J Can Assoc Radiol. 1982;33:25–27
  83. Oates E, Ramberg K. Imaging of intrathoracic disease with indium 111-labeled leukocytes. J Thorac Imaging. 1990;5:78–88
  84. Gelb AF, Dreisen RB, Epstein JD, et al. Immune complexes, gallium lung scans, and bronchoalveolar lavage in idiopathic interstitial pneumonitis-fibrosis. Chest. 1983;84:148–153
  85. Baughman RP, Fernandez M. Radionuclide imaging in interstitial lung disease. Curr Opin Pulm Med. 1996;2:376–379
  86. Schiff RG, Kabat L, Kamani N. Gallium scanning in lymphoid interstitial pneumonitis of children with AIDS. J Nucl Med. 1987;28:1915–1919
  87. Nimkin K, Oates E. Gallium-67 lung uptake in extrinsic hypersensitivity pneumonitis. Clin Nucl Med. 1989;14:451–452
  88. Brown DG, Aguirre A, Weaver A. 67Gallium scanning in talc-induced pulmonary granulomatosis. Chest. 1980;77:561–565
  89. Hayes AA, Thickbroom GW, Guelfi GR, et al. Computer quantitation of gallium 67 lung uptake in crocidolite (blue asbestos) workers of Western Australia. Eur J Nucl Med. 1990;16:855–858
  90. Deseran MW, Colletti PM, Ratto D, et al. Chronic berylliosis. Demonstration by gallium-67 imaging and magnetic resonance imaging. Clin Nucl Med. 1988;13:509–511
  91. Kanner RE, Barkman HW, Rom WN, et al. Gallium-67 citrate imaging in underground coal miners. Am J Ind Med. 1985;8:49–55
  92. Siemsen JK, Grebe SF, Waxman AD. The use of gallium-67 in pulmonary disorders. Semin Nucl Med. 1978;8:235–249
  93. Lin RY. Severe spirometric defects in systemic lupus erythematosus. A possible role for bronchoalveolar lavage and gallium scanning. Clin Rheumatol. 1987;6:276–281
  94. Baron M, Feiglin D, Hyland R, et al. 67Gallium scans in progressive systemic sclerosis. Arthritis Rheum. 1983;26:969–974
  95. Yeh SD, White DA, Stover-Pepe DE, et al. Abnormal gallium scintigraphy in pulmonary alveolar proteinosis (PAP). Clin Nucl Med. 1987;12:294–297
  96. Morais J, Carrier L, Gariepy G, et al. Gallium-67 pulmonary uptake in eosinophilic pneumonia. Clin Nucl Med. 1988;13:41–43
  97. Widman D, Swayne LC, Rozan S. Multicentric reticulo-histiocytosis: Assessment of pulmonary disease by gallium-67 scintigraphy. J Rheumatol. 1988;15:132–135
  98. Alpert LI. Pulmonary uptake of gallium-67 in Wegener's granulomatosis. Clin Nucl Med. 1980;5:53–54
  99. Javaheri S, Levine BW, McKusick KA. Serial 67Ga lung scanning in pulmonary eosinophilic granuloma. Thorax. 1979;34:822–823
  100. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med. 2001;345:517–525
  101. Line BR, Fulmer JD, Reynolds HY, et al. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation and physiologic and morphologic features and bronchoalveolar lavage. Am Rev Respir Dis. 1978;118:355–365
  102. Niederman MS, Matthay RA. New techniques for the assessment of interstitial lung disease. Radiol Clin North Am. 1983;21:667–681
  103. Pantin CF, Valind SO, Sweatman M, et al. Measures of the inflammatory response in cryptogenic fibrosing alveolitis. Am Rev Respir Dis. 1988;138:1234–1241
  104. Michaelson JE, Aguayo SM, Roman J. Idiopathic pulmonary fibrosis: A practical approach for diagnosis and management. Chest. 2000;118:788–794
  105. du Bois RM. Management of idiopathic pulmonary fibrosis: Prognostic indicators. Monaldi Arch Chest Dis. 1997;52:547–551
  106. Costabel U, King TE. International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J. 2001;17:163–167
  107. Rom WN, Bitterman PB, Rennard SI, et al. Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis. 1987;136:1429–1434
  108. Delclos GL, Flitcraft DG, Brousseau KP, et al. Bronchoalveolar lavage analysis, gallium-67 lung scanning and soluble interleukin-2 receptor levels in asbestos exposure. Environ Res. 1989;48:164–178
  109. Klaas VE. A diagnostic approach to asbestosis, utilizing clinical criteria, high resolution computed tomography, and gallium scanning. Am J Ind Med. 1993;23:801–809
  110. Ketai L, Hartshorne M. Potential uses of computed tomography-SPECT and computed tomography-coincidence fusion images of the chest. Clin Nucl Med. 2000;26:433–441
  111. Goldfarb CR, Colp C, Ongseng F, et al. Gallium scanning in the ‘new’ tuberculosis. Clin Nucl Med. 1997;22:470–474
  112. Lai FM, Liam CK, Paramsothy M, et al. The role of 67gallium scintigraphy and high resolution computed tomography as predictors of disease activity in sputum smear-negative tuberculosis. Int J Tuberc Lung Dis. 1997;1:563–569
  113. Walsh TJ, Bekerman C, Chausow A, et al. The value of gallium-67 scanning in pulmonary tuberculosis. Am Rev Respir Dis. 1985;132:746–747
  114. Goswami GK, Jana S, Santiago JF, et al. Discrepancy between Ga-67 citrate and F-18 fluorodeoxyglucose positron emission tomographic scans in pulmonary infection. Clin Nucl Med. 2000;25:490–491
  115. Utsunomiya K, Narabayashi I, Nishigaki H, et al. Clinical significance of thallium-201 and gallium-67 scintigraphy in pulmonary tuberculosis. Eur J Nucl Med. 1997;24:252–257
  116. Gulaldi NC, Bayhan H, Ercan MT, et al. The visalization of pulmonary tuberculosis with Tc-99m (V) DMSA and Tc-99m citrate in comparison to Ga-67 citrate. Clin Nucl Med. 1995;20:1012–1014
  117. Goo JM, Im JG, Do KH, et al. Pulmonary tuberculoma evaluated by means of FDG PET: Findings in 10 cases. Radiology. 2000;216:117–121
  118. Bakheet SM, Powe J, Ezzat A, et al. F-18-FDG uptake in tuberculosis. Clin Nucl Med. 1998;23:739–742
  119. Segall GM, McDougall IR. Diagnostic value of lung uptake of indium-111 oxine-labeled white blood cells. AJR Am J Roentgenol. 1986;147:601–606
  120. Cook PS, Datz FL, Disbro MA, et al. Pulmonary uptake in indium-111 leukocyte imaging: Clinical significance in patients with suspected occult infections. Radiology. 1984;150:557–561
  121. Miller JA, Lee S, Lao R, et al. Comparison of thallium-201 and gallium-67 citrate scintigraphy in the diagnosis of pulmonary disease. Chest. 1995;107:440–446
  122. Niden AH, Mishkin FS, Khurana MM, et al. 67Ga lung scan. An aid in the differential diagnosis of pulmonary embolism and pneumonitis. JAMA. 1977;237:1206–1211
  123. Moreno AJ, Weisman IM, Yedinak MA, et al. Gallium-67 citrate scintigraphy in pulmonary embolism. Clin Nucl Med. 1985;10:626–631
  124. Ashley EA, Johnson MA, Lipman MC. Human immunodeficiency virus and respiratory infection. Curr Opin Pulm Med. 2000;6:240–245
  125. Kuhlman JE. Imaging pulmonary disease in AIDS: State of the art. Eur Radiol. 1999;9:395–408
  126. Schneider RF, Rosen MJ. Pulmonary complications of HIV infections. Curr Opin Pulm Med. 1997;3:151–158
  127. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N Engl J Med. 1993;329:1922–1926
  128. Kuhlman JE. Pneumocytic infections: The radiologist's perspective. Radiology. 1996;198:623–635
  129. Oldham SA, Barron B, Munden RF, et al. The radiology of the thoracic manifestations of AIDS. Crit Rev Diagn Imaging. 1998;39:259–338
  130. Taylor A, Schuster DM, Alazraki N. Acquired immunodeficiency syndrome, in A Clinician's Guide to Nuclear Medicine. In: Reston, VA: Society of Nuclear Medicine; 2000;p. 139–152
  131. Palestro CJ, Torres MA. Radionuclide imaging of nonosseous infection. Q J Nucl Med. 1999;43:46–60
  132. Barron TF, Birnbaum NS, Shane LB, et al. Pneumocystis carinii pneumonia studied by gallium-67 scanning. Radiology. 1985;154:791–793
  133. Woolfenden JM, Carrasquillo JA, Larson SM, et al. Acquired immunodeficiency syndrome: Ga-67 citrate imaging. Radiology. 1987;162:383–387
  134. Kramer EL, Sanger JJ, Garay SM, et al. Gallium-67 scans of the chest in patients with acquired immunodeficiency syndrome. J Nucl Med. 1987;28:1107–1114
  135. Tupler RH, Turbiner EH. Scintigraphic distribution of Pneumocystis carinii pneumonia in AIDS treated with prophylactic inhaled pentamidine. Clin Nucl Med. 1991;16:772
  136. Coleman DL, Hattner RS, Luce JM, et al. Correlation between gallium lung scans and fiberoptic bronchoscopy in patients with suspected Pneumocystic carinii pneumonia and the acquired immune deficiency syndrome. Am Rev Respir Dis. 1984;130:1166–1169
  137. Kramer EL, Sanger JH, Garay SM, et al. Diagnostic implications of Ga-67 chest-scan patterns in human immunodeficiency virus-seropositive patients. Radiology. 1989;170(3 Pt 1):671–676
  138. Gruden JF, Huang L, Turner J, et al. High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings. AJR Am J Roentgenol. 1997;169:967–975
  139. Kirshenbaum KJ, Burke R, Fanapour F, et al. Pulmonary high-resolution computed tomography versus gallium scintigraphy: Diagnostic utility in the diagnosis of patients with AIDS who have chest symptoms and normal or equivocal chest radiographs. J Thorac Imaging. 1998;13:52–57
  140. Wallace JM. HIV and the lung. Curr Opin Pulm Med. 1998;4:135–141
  141. Tuazon CU, Delaney MD, Simon GL, et al. Utility of gallium67 scintigraphy and bronchial washings in the diagnosis and treatment of Pneumocystis carinii pneumonia in patients with the acquired immune deficiency syndrome. Am Rev Respir Dis. 1985;132:1087–1092
  142. Lee VW, Cooley TP, Fuller JD, et al. Pulmonary mycobacterial infections in AIDS: Characteristic pattern of thallium and gallium scan mismatch. Radiology. 1994;193:389–392
  143. Abdel-Dayem HM, DiFabrizio L, Kowalsky W, et al. Diffuse thallium lung uptake in Pneumocystis carinii pneumonia. Clin Nucl Med. 1994;19:287–291
  144. Abdel-Dayem HM, Bag R, DiFabrizio L, et al. Evaluation of sequential thallium and gallium scans of the chest in AIDS patients. J Nucl Med. 1996;37:1662–1667
  145. Fineman DS, Palestro CJ, Kim CK, et al. Detection of abnormalities in febrile AIDS patients with In-111-labeled leukocyte and Ga-67 scintigraphy. Radiology. 1989;170(3 Pt 1):677–680

PII: S0001-2998(02)80005-8

doi: 10.1053/snuc.2002.124178

Seminars in Nuclear Medicine
Volume 32, Issue 3 , Pages 193-211 , July 2002

Article Tools